Rapid induction of type I interferon expression, a central event in establishing the innate
antiviral response, requires cooperative activation of numerous transcription factors. Although …

The rapid repurposing of antivirals is particularly pressing during pandemics. However, rapid
assays for assessing candidate drugs typically involve in vitro screens and cell lines that do …

The host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection can result in prolonged pathologies collectively referred to as post-acute sequalae of …

There is an urgent need to create novel models using human disease-relevant cells to study
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biology and to facilitate …

IKKϵ is an IKK (inhibitor of nuclear factor κBkinase)–related kinase implicated in virus
induction of interferon-β (IFNβ). We report that, although mice lacking IKKϵ produce normal …

A novel variant of the SARS-CoV-2 virus carrying a point mutation in the Spike protein (D614G)
has recently emerged and rapidly surpassed others in prevalence. This mutation is in …

One of the greatest threats to humanity is the emergence of a pandemic virus. Among those
with the greatest potential for such an event include influenza viruses and coronaviruses. In …

Lung-infiltrating macrophages create a marked inflammatory milieu in a subset of patients
with COVID-19 by producing a cytokine storm, which correlates with increased lethality. …

The discovery of regulatory small RNAs continues to reshape paradigms in both molecular
biology and virology. Here we describe examples of influenza A virus-derived small viral …

SARS-CoV-2, the etiological agent of COVID-19, is characterized by a delay in type I
interferon (IFN-I)-mediated antiviral defenses alongside robust cytokine production. Here, we …